Literature DB >> 25147598

MoGAT-2 Inhibitors May Provide Effective Treatment for Hypertriglyceridemia.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2014        PMID： 25147598      PMCID： PMC4137377          DOI： 10.1021/ml500217g

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

1.  Deficiency of MGAT2 increases energy expenditure without high-fat feeding and protects genetically obese mice from excessive weight gain.

Authors:  David W Nelson; Yu Gao; Nicole M Spencer; Taylor Banh; Chi-Liang Eric Yen
Journal:  J Lipid Res       Date:  2011-07-06       Impact factor: 5.922

2.  Monoacylglycerol acyltransferase-2 is a tetrameric enzyme that selectively heterodimerizes with diacylglycerol acyltransferase-1.

Authors:  Jun Zhang; Dan Xu; Jia Nie; Jingsong Cao; Yonggong Zhai; Dewen Tong; Yuguang Shi
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

3.  MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice.

Authors:  Takuma Tsuchida; Sayaka Fukuda; Hisanori Aoyama; Nobuhiko Taniuchi; Tomomi Ishihara; Noriko Ohashi; Hiroko Sato; Koji Wakimoto; Masaharu Shiotani; Akira Oku
Journal:  Lipids Health Dis       Date:  2012-06-14       Impact factor: 3.876
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.